2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides von Jennette, J. C., Falk, R. J., Bacon, P. A., Basu, N., Cid, M. C., Ferrario, F., Flores‐Suarez, L. F., Gross, W. L., Guillevin, L., Hagen, E. C., Hoffman, G. S., Jayne, D. R., Kallenberg, C. G. M., Lamprecht, P., Langford, C. A., Luqmani, R. A., Mahr, A. D., Matteson, E. L., Merkel, P. A., Ozen, S., Pusey, C. D., Rasmussen, N., Rees, A. J., Scott, D. G. I., Specks, U., Stone, J. H., Takahashi, K., Watts, R. A.

Volltext

EULAR recommendations for the management of primary small and medium vessel vasculitis von Mukhtyar, C, Guillevin, L, Cid, M C, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C G M, Merkel, P A, Raspe, H, Salvarani, C, Scott, D G I, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R

Volltext

EULAR recommendations for the management of large vessel vasculitis von Mukhtyar, C, Guillevin, L, Cid, M C, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C G M, Merkel, P A, Raspe, H, Salvarani, C, Scott, D G I, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R

Volltext

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases von van Assen, S, Agmon-Levin, N, Elkayam, O, Cervera, R, Doran, M F, Dougados, M, Emery, P, Geborek, P, Ioannidis, J P A, Jayne, D R W, Kallenberg, C G M, Müller-Ladner, U, Shoenfeld, Y, Stojanovich, L, Valesini, G, Wulffraat, N M, Bijl, M

Volltext

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therap... von Bertsias, G, Ioannidis, J P A, Boletis, J, Bombardieri, S, Cervera, R, Dostal, C, Font, J, Gilboe, I M, Houssiau, F, Huizinga, T, Isenberg, D, Kallenberg, C G M, Khamashta, M, Piette, J C, Schneider, M, Smolen, J, Sturfelt, G, Tincani, A, van Vollenhoven, R, Gordon, C, Boumpas, D T

Volltext

The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis von Arends, S., Spoorenberg, A., Bruyn, G. A. W., Houtman, P. M., Leijsma, M. K., Kallenberg, C. G. M., Brouwer, E., van der Veer, E.

Volltext

Pathogenesis of PR3-ANCA associated vasculitis von Kallenberg, C.G.M

Volltext

Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody–Associated Vasculitis von Miloslavsky, E. M., Specks, U., Merkel, P. A., Seo, P., Spiera, R., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St.Clair, E. W., Tchao, N. K., Viviano, L., Ding, L., Sejismundo, L. P., Mieras, K., Iklé, D., Jepson, B., Mueller, M., Brunetta, P., Allen, N. B., Fervenza, F. C., Geetha, D., Keogh, K., Kissin, E. Y., Monach, P. A., Peikert, T., Stegeman, C., Ytterberg, S. R., Stone, J. H.

Volltext

Venous thromboembolism in ANCA-associated vasculitis—incidence and risk factors von Stassen, P. M., Derks, R. P. H., Kallenberg, C. G. M., Stegeman, C. A.

Volltext

Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment von Sanders, J.-S. F., Huitma, M. G., Kallenberg, C. G. M., Stegeman, C. A.

Volltext

Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis von Abdulahad, W.H., van der Geld, Y.M., Stegeman, C.A., Kallenberg, C.G.M.

Volltext

Progression of salivary gland dysfunction in patients with Sjögren’s syndrome von Pijpe, J, Kalk, W W I, Bootsma, H, Spijkervet, F K L, Kallenberg, C G M, Vissink, A

Volltext

Accelerated atherosclerosis in patients with Wegener’s granulomatosis von de Leeuw, K, Sanders, J-S, Stegeman, C, Smit, A, Kallenberg, C G, Bijl, M

Volltext

Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis von Popa, E. R., Stegeman, C. A., Abdulahad, W. H., van der Meer, B., Arends, J., Manson, W. M., Bos, N. A., Kallenberg, C. G. M., Cohen Tervaert, J.-W.

Volltext

Anti‐neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis: where to go? von Kallenberg, C. G. M.

Volltext

Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjögren's syndrome von Pijpe, J., Kalk, W. W. I., van der Wal, J. E., Vissink, A., Kluin, Ph. M., Roodenburg, J. L. N., Bootsma, H., Kallenberg, C. G. M., Spijkervet, F. K. L.

Volltext

Macrovascular disease and atherosclerosis in SSc von Hettema, M. E., Bootsma, H., Kallenberg, C. G. M.

Volltext

Wegener’s granulomatosis patients show an adequate antibody response to influenza vaccination von Holvast, A, Stegeman, C A, Benne, C A, Huckriede, A, Wilschut, J C, Palache, A M, Kallenberg, C G M, Bijl, M

Volltext

B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: A double‐blind, placebo‐controlled study von Abdulahad, W. H., Meijer, J. M., Kroese, F. G. M., Meiners, P. M., Vissink, A., Spijkervet, F. K. L., Kallenberg, C. G. M., Bootsma, H.

Volltext

10% ready-to-use intravenous human immunoglobulin offers potential economic advantages over a lyophilized product in the treatment of primary immunodeficiency von Kallenberg, C.G.M

Volltext